Abstract
Apoptosis or programmed cell death, plays an indispensable role in embryonic development, maturation of the immune system and maintenance of tissue and organ homeostasis (1–2). A wide spectrum of molecular entities including oncogenes, tumor suppressor genes, signal transducers, cell cycle proteins, free radicals, cations and proteases have been implicated in apoptosis. Recent work from our laboratory (3) demonstrated that 12-lipoxygenase (12-LOX) may play an essential role in regulating apoptosis in rat Walker carcinosarcoma (W256) cells. Down regulation of 12-LOX gene expression by antisense oligonucleotides triggered time and dose dependent apoptosis. The W256 cell death, triggered by antisense oligos could be partially blocked by exogenous 12(S)-HETE. The antisense oligo treatment also resulted in a significant decrease in the ratio of Bcl-2/Bax proteins which are critical determinants of apoptosis. As expected, over expression of Bcl-2 protein provided partial death sparing effects (3). It also was demonstrated that exogenous arachidonic acid (AA) protected against apoptosis (4). Exogenous AA in a time and dose dependent fashion suppressed NDGA induced W256 apoptosis as well as DNA fragmentation. Serum withdrawal also caused W256 cells to undergo typical apoptosis which was not rescued by several growth factors commonly found in serum. However, exogenous AA suppressed serum starvation induced W256 cell apoptosis (4). Further studies demonstrated that the factor responsible for AA induced protection against apoptosis was the 12-LOX metabolite of AA 12(S)-HETE. 12-LOX has been demonstrated by our laboratory to be expressed in numerous tumor cells from human, rat and mouse (5). Factors controlling the regulation of 12-LOX are largely unknown. Several growth factors have been shown to stimulate 12-LOX activity in tumor cells. For example, in A431, human epidermoid carcinoma cells platelet type 12-LOX is expressed (6). Serum starvation induces a time and dose dependent reduction in the expression of 12-LOX protein (8). Another cytokine which has been demonstrated to regulate 12-LOX levels in tumor cells is autocrine motility factor (AMF). AMF stimulates cell motility and invasion via receptor mediated signaling pathways. AMF is also a potent growth factor. Our laboratory demonstrated that AMF induced cell motility was mediated by the lipoxygenase generation of 12(S)-HETE (7). In a subsequent report, we also demonstrated that AMF was able to increase the cellular protein levels of 12-LOX in high but not in low metastatic clones (8).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kroemer, G., Petit, P., Zamzami, N., Vayssiere, J., and Mignottem, B. The biochemistry of programmed cell death. FASEB J. 9:1277–1287 (1995).
Manjo, G. and Joris I. Apoptosis, oncosis and necrosis. An overview of cell death. Am. J. Pathol. 146:3-15 (1995).
Tang, D.G., Chen, Y.Q., and Honn, K.V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA 93:5241–5246 (1996).
Tang, D.G., Guan, K. L., Li, L., Honn, K.V., Chen, Y.Q., Rice, R.L., Taylor, J.D., and Porter, A.T. Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int. J. Cancer 72:1078–1087 (1997).
Tang, D.G. and Honn, K.V. Eicosanoids and Tumor Cell Metastasis in: Prostaglandin Inhibitors in tuimor Immunology and Immunotherapy (Harris, J.E Braun, D.P., and Anderson, K.U., eds.), PP-73–108, CRC Press, Boca Raton. (1994).
Hagmann, W., Gao, X., Timar, J., Chen, Y.Q., Strohmaier, A.R., Fahrenkopf, C., Kagawa D., Lee, M., Zacharek, A., and Honn, K.V. 12-Lipoxy genase in A431 cells: Genetic identity, modulation of expression, and intracellular localization. Exp. Cell Res. 228:197–205 (1996).
Timar, J., Silletti, S., Bazaz, R., Raz, A., and Honn, K.V. Regulation of melanoma-cell motility by the lipoxygenase metabolite 12(S)-HETE. Int. J. Cancer 55:1003–1010 (1993).
Silletti, S., Timar, J., Honn, K.V., and Raz, A. Autocrine motility factor induces differential 12-Lipoxygenase expression and activity in high-and low-metastatic K1735 melanoma cell variants. Cancer Research 54:5752–5756 (1994).
Liu, B., Marnett, L.J., Chaudhary, A., Ji, C., Blair, I.A., Johnson, C.R., and Honn, K,V. Biosynthesis of 12(S)-hydroxyeicostatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab. Invest. 70(3):314–23 (1994).
Martin, S.J., Newmeyer, D.D., Mathias, S., et al. Cell-free reconstitution of Fas-, UV irradiation-and ceramide-induced apoptosis. EMBO J. 14:5191–5200 (1995).
Kumar, S. ICE-like proteases in apoptosis. TIBS 20: 198–202 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tang, K., Nie, D., Honn, K.V. (1999). Role of Autocrine Motility Factor in a 12-Lipoxygenase Dependent Anti-Apoptotic Pathway. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_85
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_85
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive